← All stocks

Edwards Lifesciences

EW Net selling
CIK 0001099800 #170 in the set updated 17 Sep 2026
Bought (12 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$27.68M
$3.20M on a plan · $16.73M straight out of an exercise
Sold at will
$7.76M
17 of 53 sales
Net
−$27.68M
−$7.76M against sales at will

By person

18 insiders · 54 transactions
7.9×

Mr. Zovighian holds 7.9 times base salary in stock. $9.43M of shares against $1.19M in salary for 2025.

Salary from the company's own proxy. The shares are what Mr. Zovighian last reported holding, valued at $87.51, the price Common Stock was last bought or sold at on the open market here, on 11 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
BOBO DONALD E JR
CVP,Strategy/Corp Development
$11.15M (12)
−$11.15M
121,409
0.0211%
$10.62M
−36.2%
Zovighian Bernard J
CEO
$7.00M (8) scheduled
−$7.00M
107,761
0.0187%
$9.43M
+56.6%
Ullem Scott B.
CVP, Chief Financial Officer
$3.87M (7) scheduled
−$3.87M
46,740
0.0081%
$4.09M
+52.9%
Chopra Daveen
CVP, TMTT, Surgical & IHFM
$3.19M (4) scheduled
−$3.19M
43,926
0.0076%
$3.84M
+49.7%
Markowitz Wayne
CVP, JAPAC
$1.04M (5) scheduled
−$1.04M
19,371
0.0034%
$1.70M
+90.2%
Lippis Daniel J.
CVP, TAVR
$871.62K (13) scheduled
−$871.62K
40,034
0.0069%
$3.50M
+69.9%
Bruls Annette
CVP, EMEACLA
$237.91K (1)
−$237.91K
17,984
0.0031%
$1.57M
+122.6%
STONE HEISZ LESLIE
Director
$218.12K (1)
−$218.12K
34,199
0.0059%
$2.99M
+13.9%
Dahl Andrew M.
SVP, Corporate Controller
$98.39K (2)
−$98.39K
14,615
0.0025%
$1.28M
+171.5%
Wood Larry L
Global President TAVR & Surg
206,900
0.0359%
$18.11M
−7.5%
Mistras Theodora
CVP, Chief Financial Officer
99,920
0.0173%
$8.74M
VALERIANI NICHOLAS J
Director
84,423
0.0146%
$7.39M
+14.5%
LAVIOLETTE PAUL A
Director
17,552
0.0030%
$1.54M
+62.9%
Davis Leslie C.
Director
9,834
0.0017%
$860.57K
+221.9%
Feinberg David T
Director
9,087
0.0016%
$795.20K
+293.7%
LORANGER STEVEN R
Director
8,997
0.0016%
$787.33K
Sequeira Ramona
Director
6,779
0.0012%
$593.23K
GALLAHUE KIERAN
Director
4,315
0.0007%
$377.61K
Insider
Date
Role
Action
Shares
Price
Amount
Lippis Daniel J.
11 Sep 2026
CVP, TAVR
Sold after exercise
619
$87.51
$54.17K
Dahl Andrew M.
31 Aug 2026
SVP, Corporate Controller
Sell
544
$91.06
$49.53K
Bruls Annette
28 Aug 2026
CVP, EMEACLA
Sell
2,644
$89.98
$237.91K
Markowitz Wayne
26 Aug 2026
CVP, JAPAC
Sell
1,240
$91.47
$113.42K
Chopra Daveen
26 Aug 2026
CVP, TMTT, Surgical & IHFM
Sold after exercise
30,646
$90.99
$2.79M
Chopra Daveen
26 Aug 2026
CVP, TMTT, Surgical & IHFM
Sold after exercise
1,154
$91.76
$105.89K
Lippis Daniel J.
11 Aug 2026
CVP, TAVR
Sold after exercise
619
$92.03
$56.97K
Markowitz Wayne
30 Jul 2026
CVP, JAPAC
Sell
146
$86.03
$12.59K
Markowitz Wayne
28 Jul 2026
CVP, JAPAC
Sold after exercise
9,628
$85.06
$818.96K
Zovighian Bernard J
27 Jul 2026
CEO
Sell indirect
2,921
$83.93
$245.13K
Lippis Daniel J.
10 Jul 2026
CVP, TAVR
Sold after exercise
619
$91.70
$56.76K
Lippis Daniel J.
30 Jun 2026
CVP, TAVR
Sold after exercise
619
$91.40
$56.58K
Zovighian Bernard J
17 Jun 2026
CEO
Sold on a plan indirect
523
$87.92
$45.98K
Dahl Andrew M.
29 May 2026
SVP, Corporate Controller
Sell
568
$86.08
$48.85K
BOBO DONALD E JR
27 May 2026
CVP,Strategy/Corp Development
Sell indirect
23,145
$86.42
$2.00M
Chopra Daveen
22 May 2026
CVP, TMTT & Surgical
Sell
1,500
$84.60
$126.91K
Lippis Daniel J.
18 May 2026
CVP, TAVR
Sold after exercise
620
$81.14
$50.31K
BOBO DONALD E JR
15 May 2026
CVP,Strategy/Corp Development
Sell indirect
8,000
$81.82
$654.57K
BOBO DONALD E JR
15 May 2026
CVP,Strategy/Corp Development
Sell
9,968
$82.07
$818.11K
Zovighian Bernard J
12 May 2026
CEO
Sold on a plan indirect
35,506
$77.92
$2.77M
Zovighian Bernard J
12 May 2026
CEO
Sold on a plan indirect
845
$78.40
$66.25K
Markowitz Wayne
11 May 2026
CVP, JAPAC
Sell
593
$79.73
$47.28K
Ullem Scott B.
5 May 2026
CVP, Chief Financial Officer
Exercised, kept
13,000
$59.26
$770.34K
Lippis Daniel J.
4 May 2026
CVP, TAVR
Sold after exercise
1,019
$83.98
$85.58K
Lippis Daniel J.
1 May 2026
CVP, TAVR
Sold after exercise
1,000
$82.99
$82.99K
Lippis Daniel J.
1 May 2026
CVP, TAVR
Sold after exercise
19
$83.99
$1.60K
Ullem Scott B.
9 Apr 2026
CVP, Chief Financial Officer
Sold after exercise
8,324
$79.79
$664.14K
Ullem Scott B.
9 Apr 2026
CVP, Chief Financial Officer
Sold after exercise
4,676
$80.50
$376.40K
Lippis Daniel J.
6 Apr 2026
CVP, TAVR
Sold after exercise
1,019
$80.98
$82.52K
BOBO DONALD E JR
2 Apr 2026
CVP,Strategy/Corp Development
Sold after exercise
18,004
$80.05
$1.44M
BOBO DONALD E JR
2 Apr 2026
CVP,Strategy/Corp Development
Sold after exercise
4,676
$80.59
$376.85K
Lippis Daniel J.
11 Mar 2026
CVP, TAVR
Sold after exercise
1,019
$85.38
$87.00K
Ullem Scott B.
11 Mar 2026
CVP, Chief Financial Officer
Sold after exercise
7,901
$85.21
$673.23K
Ullem Scott B.
11 Mar 2026
CVP, Chief Financial Officer
Sold after exercise
5,099
$84.46
$430.67K
BOBO DONALD E JR
2 Mar 2026
CVP,Strategy/Corp Development
Sold after exercise
11,340
$85.93
$974.43K
BOBO DONALD E JR
25 Feb 2026
CVP,Strategy/Corp Development
Sell
24,000
$83.84
$2.01M
Zovighian Bernard J
12 Feb 2026
CEO
Sold after exercise
19,898
$76.61
$1.52M
Zovighian Bernard J
12 Feb 2026
CEO
Sold after exercise
2,532
$77.13
$195.29K
Lippis Daniel J.
9 Jan 2026
CVP, TAVR
Sold after exercise
1,019
$85.70
$87.33K
BOBO DONALD E JR
6 Jan 2026
CVP,Strategy/Corp Development
Sold after exercise
8,708
$85.98
$748.71K
BOBO DONALD E JR
6 Jan 2026
CVP,Strategy/Corp Development
Sold after exercise
2,632
$84.62
$222.72K
STONE HEISZ LESLIE
12 Dec 2025
Director
Sell
2,615
$83.41
$218.12K
Lippis Daniel J.
12 Dec 2025
CVP, JAPAC
Sold after exercise
1,019
$84.03
$85.63K
BOBO DONALD E JR
12 Dec 2025
CVP,Strategy/Corp Development
Sell
5,900
$83.74
$494.07K
BOBO DONALD E JR
12 Dec 2025
CVP,Strategy/Corp Development
Sell
5,486
$83.79
$459.68K
Chopra Daveen
11 Dec 2025
CVP, TMTT & Surgical
Sell
2,000
$84.38
$168.75K
Zovighian Bernard J
10 Dec 2025
CEO
Sold on a plan indirect
3,863
$83.45
$322.37K
BOBO DONALD E JR
10 Dec 2025
CVP,Strategy/Corp Development
Sold after exercise
11,340
$83.83
$950.58K
Ullem Scott B.
9 Dec 2025
CVP, Chief Financial Officer
Sold after exercise
7,700
$84.47
$650.41K
Markowitz Wayne
8 Dec 2025
CVP, JAPAC
Sell
583
$86.01
$50.14K
Zovighian Bernard J
8 Dec 2025
CEO
Sold after exercise
21,487
$85.21
$1.83M
Lippis Daniel J.
10 Nov 2025
CVP, JAPAC
Sold after exercise
1,020
$82.55
$84.20K
Ullem Scott B.
10 Nov 2025
CVP, Chief Financial Officer
Sold after exercise
10,026
$83.02
$832.36K
Ullem Scott B.
10 Nov 2025
CVP, Chief Financial Officer
Sold after exercise
2,974
$83.30
$247.73K

What was left out

Form 4 filings counted 74
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 4
Sales straight out of an exercise 32
Sales at will 17
Transactions with no price 0
Shares from compensation/vesting 726,884
History held since 29 Aug 2016